Navigation Links
Dennis R Hill MD Receives 2013 Best of Oakland Award
Date:12/27/2013

Oakland, CA (PRWEB) December 27, 2013

Each year, the Oakland Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make the Oakland area a great place to live, work and play.

About Dr. Hill

Dr. Hill is president of Dennis R. Hill MD Professional Corporation which provides a unique emerging technology in cancer care called High Dose Rate Brachytherapy. In this method thin flexible treatment catheters are surgically implanted directly into tumor tissue and then under controlled conditions a miniature radiation source is inserted into the treatment catheters by a computerized robot. The tumor is treated from the inside out so normal tissue is spared. After treatment the catheters are removed. The cure rates are equal to surgery and external beam radiation with fewer side effects.

“I am honored to receive this award and happy to see that High Dose Rate Brachytherapy is being recognized as a new treatment alternative for cancer, specifically prostate cancer,” says Dr. Hill.

Various sources of information were gathered and analyzed to choose the winners in each category. The 2013 Oakland Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the Oakland Award Program and data provided by third parties.

About Oakland Award Program

The Oakland Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the Oakland area. Recognition is given to those companies that have shown the ability to use their best practices and implemented programs to generate competitive advantages and long-term value.

The Oakland Award Program was established to recognize the best of local businesses in our community. Our organization works exclusively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Our mission is to recognize the small business community's contributions to the U.S. economy.

SOURCE: Oakland Award Program

Contact:
Dennis R. Hill MD, 3012 Summit Street, Suite 2675, Oakland, CA 94609. Phone 510-869-8875. Fax 510-869-8882. Email drh(at)dennisrhillmd(dot)com. Website hdrprostatebrachytherapy.com.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11449077.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
2. Althea Technologies Appoints Dr. Dennis Fenton As Chairman Of Its Scientific Advisory Board
3. Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same
4. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
5. Dennis R. Hill, MD to be a Panelist at the Third Annual Prostate Cancer Symposium Focusing on the Changing Paradigm of Prostate Cancer
6. Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Discusses Prostate Cancer Stage vs. Gleason Score
7. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
8. Dennis R. Hill, MD to be a Panelist at the Third Annual Prostate Cancer Symposium Focusing on the Changing Paradigm of Prostate Cancer
9. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
10. Dennis R. Hill, MD to be a Panelist at the Third Annual Prostate Cancer Symposium Focusing on the Changing Paradigm of Prostate Cancer
11. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... February 06, 2016 , ... Contact:, Abby Mitchell, ... Excellence in Education Sponsors Teacher Training Program , Bite of Science Dinner Event ... Center for Excellence in Education (CEE) will sponsor a Bite of Science professional ...
(Date:2/5/2016)... 2016 Australian-US drug discovery and development company, Novogen ... of a new Chairman, Mr John O,Connor , and ... James Garner , has also been formally ... Acting CEO, Mr Iain Ross , will resume his ... James Garner , has also been formally appointed to ...
(Date:2/4/2016)... VA (PRWEB) , ... February ... ... cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes place February ... The two-day event features 20+ speakers and activities such as workshops and ...
(Date:2/4/2016)... ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... be held February 8-9, 2016, at the Waldorf Astoria ... & Healthcare Conference, taking place in New ... James Sapirstein , Chief Executive Officer of ContraVir, will ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/11/2016)... SAN JOSE, Calif. , Jan. 11, 2016 /PRNewswire/ ... developer of human interface solutions, today announced that its ... display driver integration (TDDI) products won two separate categories ... including Best Mobile Innovator and Best Technology Breakthrough. The ... overall system cost, a simplified supply chain, thinner devices, ...
(Date:1/7/2016)... Various factors have contributed to the ... biologics and biosimilars. Some of these factors include ... demand for cost-effective alternatives, growing burden of chronic ... versions of their corresponding patented biologic drugs, and ... and efficacy. The global biosimilars market is estimated ...
Breaking Biology News(10 mins):